Alert detail

LCD L35442: MolDX: NRAS Genetic Testing — CGS

Policy ID: LCD-L35442Specialty: OncologyAdded: 6/5/2026Effective: August 21, 2025lcd
High

What changed

New LCD for NRAS Genetic Testing affects billing practices.

Who’s affected: Oncology billing teams · Effective: August 21, 2025

Affected codes

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 5 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Oncology audit pack — $349One-time purchase · not a subscription

Not ready to subscribe?

Get the free weekly reimbursement brief for Oncology— the week’s changes and deadlines, delivered to your inbox. No account required.

LCD L35442: MolDX: NRAS Genetic Testing — CGS